Furthermore, MAMs-specific proteins MFN2 and FUNDC1 are highly expressed in cardiomyocytes and are involved in regulating mitochondrial fusion and Ca2+ homeostasis, which are expected to become potential targets for the treatment of DCM. This evidence concerns the gene FUNDC1 and familial dilated cardiomyopathy.